VMD Valuation

Viemed Healthcare Inc

Add to Watchlist

Advanced Chart

7.060

-0.010(-0.140%)

Overview
Forecast
Valuation

VMD Relative Valuation

VMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, VMD is overvalued; if below, it's undervalued.

Historical Valuation

Viemed Healthcare Inc (VMD) is now in the Fair zone, suggesting that its current forward PE ratio of 17.68 is considered Fairly compared with the five-year average of 28.68. The fair price of Viemed Healthcare Inc (VMD) is between 7.01 to 12.51 according to relative valuation methord.

Relative Value

Fair Zone

7.01-12.51

Current Price：7.06

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.11

P/B

Median3y

2.78

Median5y

3.24

0.48

FCF Yield

Median3y

2.50

Median5y

3.25

Competitors Valuation Multiple

The average P/S ratio for VMD's competitors is 0.32, providing a benchmark for relative valuation. Viemed Healthcare Inc Corp (VMD) exhibits a P/S ratio of 1.05, which is 230.75% above the industry average. Given its robust revenue growth of 19.62%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

VMD.O

Viemed Healthcare Inc

1.05

Average P/S: 0.32

19.62%